Literature DB >> 18929827

The upregulation of osteoblast marker genes in mesenchymal stem cells prove the osteoinductivity of hydroxyapatite/tricalcium phosphate biomaterial.

H Sun1, F Ye, J Wang, Y Shi, Z Tu, J Bao, M Qin, H Bu, Y Li.   

Abstract

BACKGROUND: Calcium phosphate (Ca-P), mainly concerning hydroxyapatite (HA), is the main inorganic component of the body's hard tissue. It is acknowledged that Ca-P biomaterial not only has osteoconduction but also can form bone bonding to host bone, making an ideal tissue-engineering scaffold. However, whether Ca-P biomaterial possesses osteoinductivity is still debated. The present study was performed to explore the expression level of osteoblast maker genes in human mesenchymal stem cells (hMSCs) grown on a Ca-P biomaterial.
MATERIALS AND METHODS: hMSCs were cultured on the HA/tricalcium phosphate-(TCP) double-phase ceramic. After coculture for 5, 10, 15, or 20 days, the cells were digested for isolation of total RNA. Fluorescence quantitative polymerase chain reaction was used to detect the relative mRNA levels of Runx2, collagen type I, osteopontin, and osteocalcin, all of which are the marker genes for osteoblasts. The mg63 cell was recruited as the reference and un-cocultured hMSCs as the negative controls. Alkaline phosphatase (ALP) activity in the cells was also examined after culture for 10 or 20 days.
RESULTS: Our results showed that the expression levels of all four genes continued to rise during the first 10 days. Then, both collagen type I and Runx2 decreased. In contrast, osteocalcin mRNA reached its maximum at day 15 and osteopontin mRNA kept increasing throughout the whole experimental period. Additionally, ALP activity increased in a time-dependent manner.
CONCLUSION: The up-regulation of all four osteoblast marker genes in hMSCs grown on Ca-P biomaterial suggested that HA/TCP biomaterials possess osteoinductivity on hMSCs, cells a mechanism that requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929827     DOI: 10.1016/j.transproceed.2008.07.096

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Porous hydroxyapatite and biphasic calcium phosphate ceramics promote ectopic osteoblast differentiation from mesenchymal stem cells.

Authors:  Lingli Zhang; Nobutaka Hanagata; Megumi Maeda; Takashi Minowa; Toshiyuki Ikoma; Hongsong Fan; Xingdong Zhang
Journal:  Sci Technol Adv Mater       Date:  2009-07-10       Impact factor: 8.090

2.  Osteogenic changes in kidneys of hyperoxaluric rats.

Authors:  Sunil Joshi; William L Clapp; Wei Wang; Saeed R Khan
Journal:  Biochim Biophys Acta       Date:  2015-06-27

3.  Antibacterial, anti-inflammatory, and bone-regenerative dual-drug-loaded calcium phosphate nanocarriers-in vitro and in vivo studies.

Authors:  K Madhumathi; Y Rubaiya; Mukesh Doble; R Venkateswari; T S Sampath Kumar
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

4.  Focal adhesions in osteoneogenesis.

Authors:  M J P Biggs; M J Dalby
Journal:  Proc Inst Mech Eng H       Date:  2010-12       Impact factor: 1.617

5.  The osteogenic properties of multipotent mesenchymal stromal cells in cultures on TiO₂ sol-gel-derived biomaterial.

Authors:  Krzysztof Marycz; Agnieszka Śmieszek; Jakub Grzesiak; Anna Siudzińska; Monika Marędziak; Anna Donesz-Sikorska; Justyna Krzak
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

6.  Fabrication and evaluation of porous beta-tricalcium phosphate/hydroxyapatite (60/40) composite as a bone graft extender using rat calvarial bone defect model.

Authors:  Jae Hyup Lee; Mi Young Ryu; Hae-Ri Baek; Kyung Mee Lee; Jun-Hyuk Seo; Hyun-Kyung Lee
Journal:  ScientificWorldJournal       Date:  2013-12-17

7.  The osteogenesis of bone marrow stem cells on mPEG-PCL-mPEG/hydroxyapatite composite scaffold via solid freeform fabrication.

Authors:  Han-Tsung Liao; Yo-Yu Chen; Yu-Ting Lai; Ming-Fa Hsieh; Cho-Pei Jiang
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.